SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wennberg JE, Fisher ES, Stukel TA, et al. Use of hospitals, physician visits, and hospice care during last 6 months of life among cohorts loyal to highly respected hospitals in the United States [serial online]. BMJ. 2004; 328: 607.
  • 2
    Barnato AE, Herndon MB, Anthony DL, et al. Are regional variations in end-of-life care intensity explained by patient preferences? A study of the US Medicare population. Med Care. 2007; 45: 386-393.
  • 3
    Fisher ES, Wennberg JE, Stukel TA, et al. Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors. Health Serv Res. 2000; 34: 1351-1362.
  • 4
    Wennberg JE, Freeman JL, Shelton RM, et al. Hospital use and mortality among Medicare beneficiaries in Boston and New Haven. N Engl J Med. 1989; 321: 1168-1173.
  • 5
    Danis M, Mutran E, Garrett JM, et al. A prospective study of the impact of patient preferences on life-sustaining treatment and hospital cost. Crit Care Med. 1996; 24: 1811-1817.
  • 6
    Weeks JC, Cook EF, O'Day SJ, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA. 1998; 279: 1709-1714.
  • 7
    Rose JH, O'Toole EE, Dawson NV, et al. Perspectives, preferences, care practices, and outcomes among older and middle-aged patients with late-stage cancer. J Clin Oncol. 2004; 22: 4907-4917.
  • 8
    Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008; 300: 1665-1673.
  • 9
    Dartmouth College. Dartmouth Health Atlas. Available at: http://cecsweb.dartmouth.edu/atlas08/datatools/hci_s1.php. Accessed June 10, 2010.
  • 10
    Karnofsky D, Abelmann W, Craver L, et al. The use of nitrogen mustard in the palliative treatment of cancer. Cancer. 1948; 1: 634-656.
  • 11
    Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
  • 12
    Cohen SR, Mount BM, Strobel MG, et al. The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med. 1995; 9: 207-219.
  • 13
    Prigeron HG. Socialization to dying: social determinants of death acknowledgement and treatment among terminally ill geriatric patients. J Health Soc Behav. 1992; 33: 378-395.
  • 14
    Ray A, Block SD, Friedlander RJ, et al. Peaceful awareness in patients with advanced cancer. J Palliat Med. 2006; 9: 1359-1368.
  • 15
    Earle CC, Landrum MB, Souza JM, et al. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008; 26: 3860-3866.
  • 16
    Phillips RS, Wenger NS, Teno J, et al. Choices of seriously ill patients about cardiopulmonary resuscitation: correlates and outcomes. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Med. 1996; 100: 128-137.
  • 17
    Elliot TE, Elliott BA, Renier CM. Rural-urban differences in cancer care: results from the Lake Superior Rural Cancer Care Project. Minn Med. 2004; 87: 44-50.
  • 18
    Howat A, Veitch C, Cairns W. A descriptive study comparing health attitudes of urban and rural oncology patients [serial online]. Rural Remote Health. 2006; 6: 563.
  • 19
    Sharma G, Freeman J, Zhang D, et al. Continuity of care and intensive care unit use at the end of life. Arch Intern Med. 2009; 169: 81-86.
  • 20
    Barnato AE, Bost JE, Farrell MH, et al. Relationship between staff perceptions of hospital norms and hospital-level end-of-life treatment intensity. J Palliat Med. 2007; 10: 1093-1100.
  • 21
    Fried TR, Bradley EH, Towle VR, et al. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002; 346: 1061-1066.